PS1176 PRIMARY RESULTS OF THE PHASE 4 BYOND STUDY OF BOSUTINIB FOR PRETREATED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

Authors :: F. Giles
C. Gambacorti-Passerini
Eric Leip
U. Strömberg
B.D. Smith
A. Hochhaus
C. Abboud
S. Saussele
B.T. Gjertsen
P. Giraldo-Castellano
Tim H. Brümmendorf
Andrea Viqueira
J.M. Leone
G. Rosti
J. Watts
N. Bardy-Bouxin
Source :: HemaSphere. 3:535
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: business.industry
Phase (matter)
Cancer research
Medicine
Hematology
Chronic phase chronic myeloid leukemia
business
Bosutinib
medicine.drug

Tools